Clinical Trials Directory

Trials / Completed

CompletedNCT03521908

A Study to Compare the Risk of a Major Bleeding in Participants Who Received Blood Thinning Medications Following a Blood Clot

Risk of Major Bleeding Associated With Apixaban Verses Warfarin in the Treatment of Venous Thromboembolism in US Clinical Practice

Status
Completed
Phase
—
Study type
Observational
Enrollment
35,756 (actual)
Sponsor
Bristol-Myers Squibb · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A study to compare the risk of a major bleeding in participants who received 2 different blood thinning medications following a blood clot

Conditions

Timeline

Start date
2016-06-13
Primary completion
2018-06-04
Completion
2018-11-23
First posted
2018-05-11
Last updated
2022-02-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03521908. Inclusion in this directory is not an endorsement.

A Study to Compare the Risk of a Major Bleeding in Participants Who Received Blood Thinning Medications Following a Bloo (NCT03521908) · Clinical Trials Directory